WHITEHOUSE STATION (dpa-AFX) - Avanir Pharmaceuticals Inc., an independent
subsidiary of Otsuka America Inc., has secured FDA approval for ONZETRA Xsail,
formerly known as AVP-825, for the acute treatment of migraine with or without
STOCKHOLM (dpa-AFX) - Biopharmaceutical company Cortendo has filed a
registration statement on Form F-1 with the U.S. with the SEC to raise up to
$86.25 million in an initial public offering.
The Trevose, Pennsylvania-based company's stock...
PETAH TIKVA (dpa-AFX) - ANI Pharmaceuticals, Inc. (ANIP) has acquired rights
to Testosterone Gel 1% product, previously licensed to Teva Pharmaceutical
Industries Ltd. (TEVA).
Upon commercialization, ANI will pay Teva up to $5 million at a rate...
Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of cortisol,...
Oops! Unable to complete your request. Please refresh your browser.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.